There is a rising need for decision support in the process with development of innovative medical technologies (IMTs). Further, sound approaches for early forecasting of return on IMTs, coping with the uncertainty and flexibility inherent in IMTs, are lacking. Along with the challenging economic conditions for health care over the next years and the increasing focus on IMT, it is important to develop a new approach to the estimation of the expected long term return on IMTs early on in the process of technology development.
